Search by Drug Name or NDC
NDC 63323-0464-17 Sensorcaine 2.5 mg/mL Details
Sensorcaine 2.5 mg/mL
Sensorcaine is a EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is BUPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 63323-0464 |
|---|---|
| Product ID | 63323-464_b41b5dbd-7aff-4d97-ac97-f4355393ee4e |
| Associated GPIs | 69100010102007 |
| GCN Sequence Number | 052193 |
| GCN Sequence Number Description | bupivacaine HCl/PF VIAL 2.5 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 19757 |
| HICL Sequence Number | 025243 |
| HICL Sequence Number Description | BUPIVACAINE HCL/PF |
| Brand/Generic | Brand |
| Proprietary Name | Sensorcaine |
| Proprietary Name Suffix | MPF |
| Non-Proprietary Name | BUPIVACAINE HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | BUPIVACAINE HYDROCHLORIDE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA070552 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0464-17 (63323046417)
| NDC Package Code | 63323-464-17 |
|---|---|
| Billing NDC | 63323046417 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-464-17) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-464-01) |
| Marketing Start Date | 2010-11-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |